Enrolling

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (PIKASSO-01)

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene).

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Breast Cancer, Advanced Solid Tumors
What the trial is testing?
LOXO-783
Could I receive a Placebo?
No
Enrollment Goal
400
Trial Dates
May 11, 2022 - May 2025
How long will I be in the trial?
Your participation in this trial could last up to 36 months, depending on your cancer type and how you and your tumor respond.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have advanced breast cancer or another cancer with a change in the PIK3CA gene

  • Have stopped all cancer treatment and have recovered from the major side effects

  • Have blood test results that show that organs are working adequately

  • Have a tumor that can be measured by imaging (for non-breast cancer patients) or has disease in the bones that cannot be measured by imaging (for breast cancer patients only)

Participants Must Not:

  • Have an active infection or any serious medical conditions (other than cancer)

  • Have cancer that has spread to the brain and is causing symptoms

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources

Cancer Research

Lilly has been involved in cancer research for more than fifty years, working to improve the lives of people living with cancer. Learn more about cancer research at Lilly and how you can make an impact.

Learn More

Learn About Our Early and Metastatic Breast Cancer Research

With the help of research study participants, we are learning potential new ways to improve Breast Cancer health outcomes.

Learn More

Prostate Cancer Research

By volunteering to take part in Prostate cancer clinical trials, you may be able to play an important role in the research and development of potential new treatments and medicines. We understand that when you or a loved one take part in a clinical trial, it is a big decision. It is important for you to understand why the research is being carried out and what taking part will mean for you. Learn more about Lilly

Prostate Cancer Research

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.